Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
letter
. 2010 Dec 28;55(3):1318–1319. doi: 10.1128/AAC.01585-10

NDM-1-Producing Escherichia coli in Germany

Yvonne Pfeifer 1,2,3,4, Wolfgang Witte 1,2,3,4, Martin Holfelder 1,2,3,4, Johann Busch 1,2,3,4, Patrice Nordmann 1,2,3,4,*, Laurent Poirel 1,2,3,4
PMCID: PMC3067079  PMID: 21189341

The blaNDM-1 carbapenemase gene has now been identified among many different enterobacterial species from many countries (1, 7, 10-14). Its current spread has often been associated with importations from the Indian subcontinent.

Here we report the case of a 70-year-old man admitted to the intensive care unit of a hospital in Bonn, Germany, in December 2009. This patient had been hospitalized in India 3 months before as a consequence of a trauma that made him paraplegic. An acute appendicitis associated with paralytic ileus was diagnosed at the Bonn hospital. The surgical intervention was successful, but the patient remained on a ventilator and screening for colonization produced growth of a multidrug-resistant Escherichia coli isolate from his tracheal secretions. Since no symptoms of infection occurred, no antibiotic treatment was initiated, and the patient was shortly discharged.

Antimicrobial drug susceptibility testing of the E. coli RKI isolate was performed by broth microdilution according to the guidelines of the CLSI (3). E. coli RKI was resistant to all β-lactams, including carbapenems, with MICs of imipenem and meropenem being >32 μg/ml; to all aminoglycosides; and to nitrofurantoin and sulfonamides but remained susceptible to tigecycline and fosfomycin, and the MIC of colistin was 0.5 μg/ml. PCR and sequencing were performed in searching of different carbapenemase and extended-spectrum β-lactamase (ESBL) genes and also for blaOXA genes as described previously (5, 9). These procedures showed that E. coli RKI harbored the blaNDM-1, blaCTX-M-15, blaTEM-1, blaOXA-1, and blaOXA-2 genes.

In addition, PCR performed as described previously (4, 6, 11) revealed that E. coli RKI harbored the aac(6)1b-cr gene, encoding resistance to aminoglycosides and reduced susceptibility to ciprofloxacin, together with the 16S rRNA methylase gene rmtC, conferring high-level resistance to all aminoglycosides, although no qnr gene was detected.

Transfer of the blaNDM-1 gene was attempted by conjugation or electrotransformation (11) into a sodium azide-resistant E. coli J53 recipient strain, but the effort was unsuccessful. S1 nuclease pulsed-field gel electrophoresis (PFGE) analysis, performed as previously described (1), revealed two plasmids in E. coli RKI (120 and 70 kb, respectively) that did not hybridize with a blaNDM-1-specific probe. Investigation of the blaNDM-1 genetic environment by PCR mapping using primers designed according to previously identified blaNDM-1-associated structures (11) revealed that the blaNDM-1 genetic context in E. coli RKI was different from those previously identified, further underlining that the current dissemination of blaNDM-1 was not associated with a single specific genetic structure.

Multilocus sequence typing (MLST) (http://mlst.ucc.ie/mlst/dbs/Ecoli) and PCR-based phylogroup analysis (2) identified E. coli RKI as an ST101 strain belonging to phylogroup B1. Interestingly, the NDM-1-positive E. coli 271 strain recently identified from Australia (11) with a link to the Indian subcontinent had also been identified as an ST101 strain. However, pulsed-field gel electrophoresis analysis (10) of E. coli RKI and E. coli 271 did not reveal any genetic relatedness.

This study further indicates that NDM-1-producing Enterobacteriaceae are currently spreading worldwide. Here we report a very likely chromosomal position of the blaNDM-1 gene in E. coli, demonstrating that the genetic structures surrounding that gene might allow its integration in the bacterial chromosome.

Notably, the NDM-1-producing isolate also expressed other resistance determinants, in particular an ESBL and a 16S RNA methylase, leading to a panresistance phenotype. Our study is the first to evidence the occurrence of NDM-1-producing E. coli strains in Germany, with a link to previous hospitalization in India; this constitutes a warning to authorities to reinforce strict control measures for preventing the spread of such multidrug-resistant strains.

Acknowledgments

We thank George A. Jacoby for providing the E. coli J53 Azir recipient strain and Lina Cavaco and Beatriz Guerra for providing Qnr control strains, as well as Petra Edquist for providing the NDM-1 control strain. We extend special thanks to Sybille Müller-Bertling for performing phenotypic and genotypic analyses.

This work was funded by the Ministry of Health, Germany, and by the INSERM (U914), Paris, France.

Footnotes

Published ahead of print on 28 December 2010.

REFERENCES

  • 1.Centers for Disease Control and Prevention. 2010. Detection of Enterobacteriaceae isolates carrying metallo-β-lactamase—United States. MMWR Morb. Mortal. Wkly. Rep. 59:750. [PubMed] [Google Scholar]
  • 2.Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing. CLSI M100-S20U. Clinical and Laboratory Standards Institute, Wayne, PA.
  • 4.Doi, Y., and Y. Arakawa. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin. Infect. Dis. 45:88-94. [DOI] [PubMed] [Google Scholar]
  • 5.Gröbner, S., et al. 2009. Emergence of carbapenem-non-susceptible extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J. Med. Microbiol. 58:912-922. [DOI] [PubMed] [Google Scholar]
  • 6.Kim, S. Y., Y. J. Park, J. K. Yu, Y. S. Kim, and K. Han. 2009. Prevalence and characteristics of aac(6)1b-cr in AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens: a multicenter study from Korea. Diagn. Microbiol. Infect. Dis. 63:314-318. [DOI] [PubMed] [Google Scholar]
  • 7.Kumarasamy, K. K., et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597-602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Reference deleted.
  • 9.Pfeifer, Y., J. Matten, and W. Rabsch. 2009. Salmonella enterica serovar Typhi with CTX-M β-lactamase, Germany. Emerg. Infect. Dis. 15:1533-1535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Poirel, L., Z. Al Maskari, F. Al Rashdi, S. Bernabeu, and P. Nordmann. 2011. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J. Antimicrob. Chemother. 66:304-306. [DOI] [PubMed] [Google Scholar]
  • 11.Poirel, L., E. Lagrutta, P. Taylor, J. Pham, and P. Nordmann. 2010. Emergence of metallo-β-lactamase NDM-1-producing multidrug resistant Escherichia coli in Australia. Antimicrob. Agents Chemother. 54:4914-4916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Poirel, L., J. D. Pitout, and P. Nordmann. 2007. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2:501-512. [DOI] [PubMed] [Google Scholar]
  • 13.Poirel, L., et al. 2011. Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob. Agents Chemother. 55:447-448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yong, D., et al. 2009. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES